Free Trial

Rezolute (RZLT) Stock Forecast & Price Target

Rezolute logo
$4.94 -0.07 (-1.40%)
(As of 11:50 AM ET)

Rezolute - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
8

Based on 8 Wall Street analysts who have issued ratings for Rezolute in the last 12 months, the stock has a consensus rating of "Buy." Out of the 8 analysts, 8 have given a buy rating for RZLT.

Consensus Price Target

$24.13
388.36% Upside
According to the 8 analysts' twelve-month price targets for Rezolute, the average price target is $24.13. The highest price target for RZLT is $112.00, while the lowest price target for RZLT is $7.00. The average price target represents a forecasted upside of 388.36% from the current price of $4.94.
Get the Latest News and Ratings for RZLT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Rezolute and its competitors.

Sign Up

RZLT Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$24.13$11.57$10.43$8.67
Forecasted Upside388.36% Upside118.74% Upside142.52% Upside1,029.50% Upside
Consensus Rating
Buy
Buy
Buy
Buy

RZLT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RZLT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Rezolute Stock vs. The Competition

TypeRezoluteMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.80
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside388.36% Upside27,212.41% Upside8.86% Upside
News Sentiment Rating
Positive News

See Recent RZLT News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/8/2024HC Wainwright
2 of 5 stars
 Reiterated RatingBuy ➝ Buy$14.00 ➝ $14.00+151.35%
11/4/2024Wedbush
4 of 5 stars
Y. Zhong
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$112.00+1,958.82%
9/20/2024JMP Securities
2 of 5 stars
 Reiterated RatingMarket Outperform ➝ Market Outperform$7.00 ➝ $7.00+40.84%
9/10/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Harrison
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$13.00 ➝ $15.00+186.26%
8/27/2024Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Chattopadhyay
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$11.00+134.04%
8/6/2024Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$8.00 ➝ $10.00+129.88%
6/4/2024Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Schwab
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$14.00+240.63%
4/18/2024Jonestrading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$10.00+208.64%
9/19/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Stavropoulos
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$5.00+237.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 12:19 PM ET.


RZLT Forecast - Frequently Asked Questions

According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Rezolute is $24.13, with a high forecast of $112.00 and a low forecast of $7.00.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rezolute in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RZLT shares.

According to analysts, Rezolute's stock has a predicted upside of 388.36% based on their 12-month stock forecasts.

Rezolute has been rated by research analysts at BTIG Research, Guggenheim, HC Wainwright, JMP Securities, and Wedbush in the past 90 days.

Analysts like Rezolute more than other "medical" companies. The consensus rating for Rezolute is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how RZLT compares to other companies.


This page (NASDAQ:RZLT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners